| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |